Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Date:2/21/2012

ifferences include, but are not limited to: challenges, risks and costs inherent in business integrations and in achieving anticipated synergies; the effect of any changes in customer and supplier relationships and customer purchasing patterns; the ability to attract and retain key personnel; changes in third-party relationships; the impacts of competition; changes in economic and financial conditions of the Company's business; uncertainties and matters beyond the control of management; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with GAAP and related standards. These cautionary statements should be considered in connection with any subsequent written or oral forward-looking statements that may be made by the Company or by persons acting on its behalf and in conjunction with its periodic SEC filings. In addition, please refer to the cautionary statements and risk factors set forth in the Company's Report on Form 10-Q, for the quarter ended September 30, 2011, and in its other filings with the SEC. Further, uncertainties or other circumstances, or matters outside of the Company's control between the date of this release and the date that its Form 10-K for the year ended December 31, 2011, is filed with the SEC could potentially result in adjustments to reported results. The Company undertakes no obligation to update statements herein for revisions or changes after the date of this release.

Mylan Inc. and SubsidiariesCondensed Consolidated Statements of Operations(Unaudited; in thousands, except per share amounts)Three Months Ended December 31,Year Ended December 31,2011201020112010Revenues:Net revenues$ 1,527,062$ 1,424,618$ 6,106,277$ 5,404,266Other revenues4,1729,88123,54846,256Total revenues1,531,2341,434,4996,129,8255,450,522Cost of sales886,636855,3073,566,4613,233,125Gross profit644,598579,1922,563,3642,217,397Operat
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
2. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
3. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
4. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
5. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
6. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
7. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
8. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
9. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
10. Mylan Launches First Generic Version of Teveten® Tablets
11. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... presenting at the Morgan Stanley Global Healthcare Conference on ... Nevro management is scheduled to present at ... a live audio webcast, accessible in the "Investors" section ...
(Date:9/3/2015)... 2015  As part of its ongoing commitment to ... Marc R. Katz , MD, MPH, cardiac surgeon and ... Vascular Institute implanted the first HeartMate 3 left ventricular ... selected as part of the prestigious MOMENTUM 3™ Clinical ... in the United States—and the first in central Virginia—chosen ...
(Date:9/3/2015)... , Novel ideas for ... for translation of findings into practice ...   , On occasion of the 9 th ... scientists from across Europe presented the latest ... potential for achieving major advances in pain management. All presenters were ...
Breaking Medicine Technology:Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 2Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 3Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 4Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 5
(Date:9/3/2015)... ... September 03, 2015 , ... ... applications are open for spring 2016. Scholarships are awarded two times each year ... The Warriors® is a national nonprofit dedicated to restoring a sense of self, ...
(Date:9/3/2015)... PEACHTREE CITY, GA (PRWEB) , ... September 03, ... ... does not cover the cost of graduated compression garments. However, graduated compression garments ... management. , Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... the real estate investment landscape by connecting accredited and institutional investors to real ... financing products designed to meet demand from both investors and sponsoring real ...
(Date:9/3/2015)... St. Louis, MO (PRWEB) , ... September 03, 2015 , ... ... NBC Nightly News*, covering the allegations made by IVC filter lawsuits filed ... allege they were harmed when a Bard IVC filter broke or failed, have recently ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Linda Hall Library ... of a comet, the IceCube observatory at the South Pole, and the interior of ... Fall Lecture Series for the world's foremost independently funded research library devoted to science, ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 2Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 3Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 4Health News:Facing the Frontiers of Science and Technology The Linda Hall Library Announces 2015 Fall Lecture Series Featuring Experiences from the South Pole to Outer Space 5
... dose of phenylephrine works. , , FRIDAY, Dec. 14 (HealthDay ... popular over-the-counter cold medicines is effective at its current ... , The panel of advisers to the U.S. Food ... OTC cold medicines containing the decongestant phenylephrine really provide ...
... Think Twice Before Leaving Your Luggage On A Hotel Bed And Other ... ... Briggs & Riley Travelware, a,leader in innovative, high quality luggage, reports ... health and sanitation,at tourist attractions and travel hotspots, according to a poll ...
... Dec. 14 /PRNewswire-FirstCall/ - Cardiome Pharma Corp.,(NASDAQ: CRME/TSX: COM) ... held on Friday, December 14, 2007 at 2:00pm Eastern,(11:00am ... To access the conference call, please dial 416-340-8010 ... analysts on which,we will respond to questions at the ...
... Dec. 14 The U.S. Conference of,Catholic Bishops ... Pregnant Women,s Support Act (S. 2407), a bill ... "By providing practical resources and information, the bill ... themselves and their,children, born and unborn," said Ms. ...
... Calif., Dec. 14 Watson,Pharmaceuticals, Inc. (NYSE: ... confirmed today that Duramed Pharmaceuticals, Inc., a ... filed a patent lawsuit,against Watson and certain ... tablets USP), Watson,s generic version of,Seasonale(R), an ...
... have a history of abuse by intimate partners have higher ... of abuse, according to a study conducted at Group Health, ... terms of the cost of providing care and use of ... children were born, the research team found. Scientists from ...
Cached Medicine News:Health News:FDA Panel Finds OTC Cold Remedies Effective 2Health News:FDA Panel Finds OTC Cold Remedies Effective 3Health News:Briggs & Riley Reports That More Travelers Focus on Health and Sanitation This Holiday Season 2Health News:Briggs & Riley Reports That More Travelers Focus on Health and Sanitation This Holiday Season 3Health News:Cardiome to Hold Investor Update Call 2Health News:Cardiome to Hold Investor Update Call 3Health News:Cardiome to Hold Investor Update Call 4Health News:Bishops' Conference Praises Senate Introduction of 'Pregnant Women Support Act' 2Health News:Watson Confirms Patent Litigation With Barr Related to Seasonale(R) 2Health News:Health needs higher for kids of abused moms 2Health News:Health needs higher for kids of abused moms 3
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... Only 1-2% of circulating testosterone exists ... approximately 60%, is bound to SHBG with ... loosely bound to albumin. Both the albumin-bound ... while SHBG effectively inhibits testosterone action. Measurement ...
RIA kit for the quantitative determination of autoantibodies to steroid 21-hydroxylase (21-OH) in serum....
6700 Reagent Reservoirs, 120 mL...
Medicine Products: